Disruption of lamin B1 and lamin B2 processing and localization by farnesyltransferase inhibitors
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Disruption of lamin B1 and lamin B2 processing and localization by farnesyltransferase inhibitors
Authors
Keywords
-
Journal
Nucleus
Volume 4, Issue 2, Pages 142-150
Publisher
Informa UK Limited
Online
2013-03-08
DOI
10.4161/nucl.24089
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Local Translation of Extranuclear Lamin B Promotes Axon Maintenance
- (2012) Byung C. Yoon et al. CELL
- Lamin B1 loss is a senescence-associated biomarker
- (2012) Adam Freund et al. MOLECULAR BIOLOGY OF THE CELL
- Clinical trial of a farnesyltransferase inhibitor in children with Hutchinson-Gilford progeria syndrome
- (2012) L. B. Gordon et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Blocking farnesylation of the prelamin A variant in Hutchinson-Gilford progeria syndrome alters the distribution of A-type lamins
- (2012) Yuexia Wang et al. Nucleus
- Lamin A, farnesylation and aging
- (2011) Sita Reddy et al. EXPERIMENTAL CELL RESEARCH
- The role of nuclear lamin B1 in cell proliferation and senescence
- (2011) T. Shimi et al. GENES & DEVELOPMENT
- An absence of both lamin B1 and lamin B2 in keratinocytes has no effect on cell proliferation or the development of skin and hair
- (2011) Shao H. Yang et al. HUMAN MOLECULAR GENETICS
- Severe hepatocellular disease in mice lacking one or bothCaaXprenyltransferases
- (2011) Shao H. Yang et al. JOURNAL OF LIPID RESEARCH
- Nuclear lamina at the crossroads of the cytoplasm and nucleus
- (2011) Larry Gerace et al. JOURNAL OF STRUCTURAL BIOLOGY
- Deficiencies in lamin B1 and lamin B2 cause neurodevelopmental defects and distinct nuclear shape abnormalities in neurons
- (2011) Catherine Coffinier et al. MOLECULAR BIOLOGY OF THE CELL
- Protein farnesylation inhibitors cause donut-shaped cell nuclei attributable to a centrosome separation defect
- (2011) V. L. R. M. Verstraeten et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Mouse B-Type Lamins Are Required for Proper Organogenesis But Not by Embryonic Stem Cells
- (2011) Y. Kim et al. SCIENCE
- Phase I and pharmacokinetic study of lonafarnib, SCH 66336, using a 2-week on, 2-week off schedule in patients with advanced solid tumors
- (2010) Carlos Castaneda et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Genetic studies on the functional relevance of the protein prenyltransferases in skin keratinocytes
- (2010) Roger Lee et al. HUMAN MOLECULAR GENETICS
- An accumulation of non-farnesylated prelamin A causes cardiomyopathy but not progeria
- (2010) B. S. J. Davies et al. HUMAN MOLECULAR GENETICS
- Absence of progeria-like disease phenotypes in knock-in mice expressing a non-farnesylated version of progerin
- (2010) Shao H. Yang et al. HUMAN MOLECULAR GENETICS
- Abnormal development of the cerebral cortex and cerebellum in the setting of lamin B2 deficiency
- (2010) C. Coffinier et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A progeria mutation reveals functions for lamin A in nuclear assembly, architecture, and chromosome organization
- (2009) P. Taimen et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The A- and B-type nuclear lamin networks: microdomains involved in chromatin organization and transcription
- (2008) T. Shimi et al. GENES & DEVELOPMENT
- Sumoylation regulates lamin A function and is lost in lamin A mutants associated with familial cardiomyopathies
- (2008) Yu-Qian Zhang et al. JOURNAL OF CELL BIOLOGY
- Progerin elicits disease phenotypes of progeria in mice whether or not it is farnesylated
- (2008) Shao H. Yang et al. JOURNAL OF CLINICAL INVESTIGATION
- Combined treatment with statins and aminobisphosphonates extends longevity in a mouse model of human premature aging
- (2008) Ignacio Varela et al. NATURE MEDICINE
- A farnesyltransferase inhibitor prevents both the onset and late progression of cardiovascular disease in a progeria mouse model
- (2008) B. C. Capell et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now